Gonorrhea

Active Ingredient: Cefotaxime

Indication for Cefotaxime

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

For this indication, competent medicine agencies globally authorize below treatments:

0.5 g once

Route of admnistration

Intravenous

Defined daily dose

0.5 - 0.5 g

Dosage regimen

From 0.5 To 0.5 g once every day for 1 day(s)

Detailed description

For the treatment of gonorrhoea in adults, 500mg administered as a single administration.

Dosage considerations

For IV, cefotaxime for injection 500 mg is dissolved in at least 2 ml water for injections, cefotaxime for injection 1 g in at least 4 ml and subsequently injected directly into the vein over 3 to 5 minutes or after clamping of the infusion tube into the distal end of the tube. During post-marketing surveillance, potentially life-threatening arrhythmia has been reported in a very few patients who received rapid intravenous administration of cefotaxime through a central venous catheter.

Infusion

For brief infusion 2 g of cefotaxime for injection is dissolved in 100 ml of isotonic sodium chloride or glucose solution and subsequently IV infused over 50 to 60 minutes. Another compatible infusion solution can also be used for the solution.

0.5 g once

Route of admnistration

Intramuscular

Defined daily dose

0.5 - 0.5 g

Dosage regimen

From 0.5 To 0.5 g once every day for 1 day(s)

Detailed description

For the treatment of gonorrhoea in adults, 500 mg administered as a single administration.

Dosage considerations

Cefotaxime for injection 500 mg is dissolved in 2 ml and cefotaxime for injection 1 g in 4 ml water for injections respectively. Afterwards the injection should take place deep into the gluteal muscle. Pain with the IM injection can be avoided by dissolving cefotaxime for injection 500mg in 2ml or cefotaxime for Injection 1 g in 4 ml 1% lidocaine solution. An intravascular injection is to be avoided in this case, since with intravascular administration lidocaine may lead to unrest, tachycardia, disturbances of cardiac conduction as well as vomiting and cramp. Cefotaxime reconstituted with lidocaine should not be administered to infants under 30 months.

It is recommended that no more than 4 ml be injected unilaterally. If the daily dose exceeds 2 g cefotaxime or if cefotaxime is injected more frequently than twice per day, the IV route is recommended.

Active ingredient

Cefotaxime

Cefotaxime exerts its action by binding to one or more of the penicillin-binding proteins (PBPs) which in turn inhibits the final transpeptidation step of peptidoglycan synthesis in bacterial cell walls, thereby inhibiting cell wall synthesis.

Read more about Cefotaxime

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner

Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.